Emerged in 2012 in the Middle East, causing sporadic outbreaks with cases reported in several countries.

The high mortality rate associated with MERS-CoV infections (around 35%) raised concerns about the potential for wider outbreaks and the need for effective treatment options and preventive measures.

While the overall number of MERS cases remained relatively low compared to other respiratory viruses like SARS-CoV-2, its potential for causing severe illness and the possibility of zoonotic transmission underscored the importance of ongoing surveillance and preparedness for emerging infectious diseases.
